Catalyst Pharmaceuticals, Inc. · NASDAQ:CPRX

BlackRock, Inc. reported a 13.90% stake in Catalyst Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 28, 2025

BlackRock, Inc. reported a 13.90% stake in Catalyst Pharmaceuticals, Inc., 16,892,951 shares, as a passive investor on Mar 31, 2025. Filed Apr 28, 2025 (Schedule 13G/A).

Stake
13.90%
Shares
16,892,951
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.13.90%16,892,951

Source

View original at SEC

Related